3VCO

Schistosoma mansoni Dihydrofolate reductase

3VCO の概要

• エントリーDOI: 10.2210/pdb3vco/pdb
• 分子名称: Dihydrofolate reductase, SULFATE ION (3 entities in total)
• 機能のキーワード: reductase, oxidoreductase
• 由来する生物種: Schistosoma mansoni (Blood fluke)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 22968.26

構造登録者

Serrao, V.H.B.,Romanello, L.,Cassago, A.,DeMarco, R.,Pereira, H.M. (登録日: 2012-01-04, 公開日: 2013-03-06, 最終更新日: 2023-09-13)

主引用文献

Serrao, V.H.B.,Romanello, L.,Cassago, A.,de Souza, J.R.T.,Cheleski, J.,DeMarco, R.,Brandao-Neto, J.,Pereira, H.D.
Structure and kinetics assays of recombinant Schistosoma mansoni dihydrofolate reductase.
Acta Trop., 170:190-196, 2017

PubMed Abstract: The parasite Schistosoma mansoni possesses all pathways for pyrimidine biosynthesis, in which dihydrofolate reductase (DHFR), thymidylate cycle participants, is essential for nucleotide metabolism to obtain energy and structural nucleic acids. Thus, DHFRs have been widely suggested as therapeutic targets for the treatment of infectious diseases. In this study, we expressed recombinant SmDHFR in a heterologous manner to obtain structural, biochemical and kinetic information. X-ray diffraction of recombinant SmDHFR at 1.95Å resolution showed that the structure exhibited the canonical DHFR fold. Isothermal titration calorimetry was used to determine the kinetic constants for NADP and dihydrofolate. Moreover, inhibition assays were performed using the commercial folate analogs methotrexate and aminopterin; these analogs are recognized as folate competitors and are used as chemotherapeutic agents in cancer and autoimmune diseases. This study provides information that may prove useful for the future discovery of novel drugs and for understanding these metabolic steps from this pathway of S. mansoni, thus aiding in our understanding of the function of these essential pathways for parasite metabolism.

PubMed: 28288799
DOI: 10.1016/j.actatropica.2017.03.007

実験手法

X-RAY DIFFRACTION (1.946 Å)